Euthyroid FT3 Levels Linked to Sarcopenia Risk in T2DM Tags Diabetic myonecrosis ('muscle wasting') Read more about Euthyroid FT3 Levels Linked to Sarcopenia Risk in T2DM
FIB-4, NFS Show Limited Accuracy in T2DM–MASLD Tags Lipohypertrophy Read more about FIB-4, NFS Show Limited Accuracy in T2DM–MASLD
Poor Glycemic Control Linked to Mortality in Critically Ill Patients with COVID-19 Tags FBS ORAL GTT PLBS RBS Read more about Poor Glycemic Control Linked to Mortality in Critically Ill Patients with COVID-19
At-Home HbA1c Screening Shows Feasibility in Denmark Tags hBA1c Read more about At-Home HbA1c Screening Shows Feasibility in Denmark
Novel CGM-Based ST Ratio Explored as Measure of Glycemic Variability in Type 1 Diabetes Tags FBS RBS Read more about Novel CGM-Based ST Ratio Explored as Measure of Glycemic Variability in Type 1 Diabetes
Anagliptin/Metformin Showed Stable Lactic Acid Levels in CKD Tags Diabetic Nephropathy Read more about Anagliptin/Metformin Showed Stable Lactic Acid Levels in CKD
OGTT-Derived mDI-woI Associated With Earlier Identification of Type 2 Diabetes Risk Than Conventional Biomarkers in Longitudinal Cohort Tags ORAL GTT Read more about OGTT-Derived mDI-woI Associated With Earlier Identification of Type 2 Diabetes Risk Than Conventional Biomarkers in Longitudinal Cohort
Missing Baseline HbA1c Associated With Higher Risk of Cardiovascular Events or Death in Newly Diagnosed Diabetes Tags Coronary artery disease Myocardial infarction Peripheral vascular disease Stroke hBA1c Read more about Missing Baseline HbA1c Associated With Higher Risk of Cardiovascular Events or Death in Newly Diagnosed Diabetes
Prediagnostic Biomarkers Associated With Type 2 Diabetes but Limited for Subtype Differentiation Tags Peripheral vascular disease hBA1c Read more about Prediagnostic Biomarkers Associated With Type 2 Diabetes but Limited for Subtype Differentiation
Real-Time CGM May Significantly Improve Glycemic Control Across T2D Treatment Strategies Tags SCREENING GTT SGLT-2 Inhibitor Read more about Real-Time CGM May Significantly Improve Glycemic Control Across T2D Treatment Strategies